The invention provides monoferrocenyl compounds of general formula I. The invention also provides substrates labelled with the compounds, functionalised derivatives of the compounds and methods of using the compounds, functionalised derivatives and labelled substrates in electrochemical assays.

This invention concerns a versatile and simple one-pot method to prepare nanomaterials, and in particular nanoparticles, grafted with an ultra-thin layer of calixarenes by placing at 5 least one oxidized metal with at least one calix[n]arene diazonium salt in the presence of a reducing agent in a solvent, and heating the traction mixture to obtain a metal-based nanomaterial coated with calix[n]arenes. The invention further concerns the coupling of organic molecules or biomolecules to the calixarene-grafted nanomaterials in order to further functionalize the surface of the particles. The metal-based nanomaterial coated with 10 calix[n]arenes can for example be used in immunoassays.

A magnetic resonance imaging (MRI) contrast agent and a preparation method and a use thereof is provided, which belong to the technical field of Magnetic Resonance Imaging contrast agent. The MRI contrast agent is prepared by the compound having a structure of formula I; and it also may include the compound having a structure of formula II or a pharmaceutically acceptable salt thereof, wherein M.sub.1 is a divalent ion or a trivalent ion of a paramagnetic metal selected from Mn, Fe, Eu, or Dy; M.sub.2 is selected from Na.sup.+, K.sup.+ or meglumine cation; when M.sub.1 is a divalent ion, a is 2; when M.sub.1 is a trivalent ion, a is 3. The MRI contrast agent has good water solubility, high relaxivity, and low toxic and side effect.

##STR00001##

The present invention relates to a process for the preparation of polyaminocarboxylic acids, in particular phenolic aryl- or alkyldiaminepolycarboxylic acids, preferably a compound of formula (I): wherein X is selected from the group consisting of: H, COOH, COO.sup.−Y.sup.+, OH, linear or branched C.sub.1-C.sub.5 alkyl, CH.sub.2OH, SO.sub.3H, SO.sub.3.sup.−Y.sup.+, wherein: —Y.sup.+ is independently selected from the group consisting of: Li.sup.+, Na.sup.+, K.sup.+, and NH.sub.4.sup.+; and wherein A is selected from: —A (CH.sub.2)n linear aliphatic system, wherein n=2, 3 or 4, preferably 2 or 3; and —an aromatic system of formula (II): wherein R1, R2 are independently selected from the group consisting of H, OH, and linear or branched C.sub.1-C.sub.5 alkyl; said process comprising the step of reacting, a phenol compound, glyoxylic acid and an aryl- or alkyldiamine in the presence of an iron source to obtain a reaction mixture comprising the compound of formula (I). The invention also relates to a process for the preparation of a chelate compound, which is a complex of the compound of formula (I) with iron.

The titanium (IV) and iron (III) MOF solid MUV-17 (TiFe.sub.2), has general formula (1): [Ti.sup.IVFe.sup.III.sub.2(O)(L).sub.2(X).sub.3]S, where X is each equal or different selected from: O.sup.2−, OH.sup.−, H.sub.2O, F.sup.−, Cl.sup.−, Br.sup.−, I.sup.−, NO.sub.3.sup.−, ClO.sub.4.sup.−, BF.sub.4.sup.−, SCN.sup.−, OH.sup.−, CH.sub.3COO.sup.−, C.sub.5H.sub.7O.sub.2.sup.−, SO.sub.4.sup.2− and CO.sub.3.sup.2−, L is a tricarboxylic ligand and S is at least one molecule of a polar solvent selected from the group consisting of N,N′-dimethylformamide,N,N′-diethylformamide,N,N′-dimethylacetamide, N-methyl-2-pyrrolidone, methanol, ethanol, isopropanol, n-propanol, water and mixtures thereof. The titanium (IV) and iron (III) MOF solid has long-term catalytic activity for the degradation of toxic compounds. The method for obtaining them comprises dissolving the components under anaerobic conditions. The invention also relates to the use of the titanium (IV) and iron (III) MOF solid as an additive with detoxifying properties of toxic compounds.

Embodiments of the present disclose provide a method of sorbing one or more compounds from a fluid, wherein the method may include contacting a M-soc-MOF composition with a fluid containing at least H.sub.2S and one or more of CO.sub.2 and CH.sub.4; and sorbing at least H.sub.2S from the fluid. Embodiments of the present disclosure provide a membrane that may include a metal-organic framework (MOF) composition, wherein the MOF composition includes a M-soc-MOF composition, where M is a metal and soc is a square-octahedral topology, and wherein the M-soc-MOF composition is a continuous thin film on a support.

The present invention relates to an iron complex having the general formula (I) or a pharmaceutically acceptable salt thereof. The present invention also relates to a pharmaceutical composition formulated for oral and/or parenteral administration, preferably intravenous, said pharmaceutical composition preferably being formulated as an aqueous solution comprising said complex or salt. The present invention further relates to said complex or a salt thereof or said pharmaceutical composition for use as a contrast agent for magnetic resonance imaging (MRI), as well as a method and a kit for in situ preparation of said complex or salt and said pharmaceutical composition.

The present invention relates to a process for preparing a metal-chelate retarder by a sol-gel method. The method comprises the following steps: weighing calcium nitrate tetrahydrate, aluminum nitrate nonahydrate and ferric nitrate nonahydrate according to a certain mass ratio and adding them into deionized water; placing the mixed solution on a magnetic stirrer and stirring the mixed solution evenly; adding citric acid monohydrate or gluconic acid, ethylene glycol or glycerol, and placing the mixed solution into a water bath to react to obtain the metal-chelate retarder. The process of the present invention has a reliable principle, overcomes the defects of long production period, complex preparation and the like of the existing retarders, has the advantages of simple process operation, cheap and easily available raw materials, and short production period. The prepared retarder has wide temperature adaptation range and adjustable thickening time, is suitable for large-scale industrial production, and has a wide market application prospect.

The present invention relates to a process for preparing a metal-chelate retarder by a sol-gel method. The method comprises the following steps: weighing calcium nitrate tetrahydrate, aluminum nitrate nonahydrate and ferric nitrate nonahydrate according to a certain mass ratio and adding them into deionized water; placing the mixed solution on a magnetic stirrer and stirring the mixed solution evenly; adding citric acid monohydrate or gluconic acid, ethylene glycol or glycerol, and placing the mixed solution into a water bath to react to obtain the metal-chelate retarder. The process of the present invention has a reliable principle, overcomes the defects of long production period, complex preparation and the like of the existing retarders, has the advantages of simple process operation, cheap and easily available raw materials, and short production period. The prepared retarder has wide temperature adaptation range and adjustable thickening time, is suitable for large-scale industrial production, and has a wide market application prospect.

A pyrazole metal complex for absorption of carbon dioxide, a method for preparing the pyrazole metal complex, and a method for absorbing carbon dioxide are provided; wherein the product produced by reacting pyrazole metal complex and carbon dioxide may be transformed into several economically valuable compounds.